Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c00166 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2024. Written by Xikuang Yao and 7 co-authors. Institution: School of Flexible Electronics (Future Technologies) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211816…. Major MEDLINE topics: Polyethylene Glycols, Neoplasms, Peptides. Cited 23 times so far (Crossref); 26 references. Funded by: China Pharmaceutical University, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (original language)
Nanomedicine-enhanced immunogenic cell death (ICD) has attracted considerable attention for its great potential in cancer treatment. Even though polyethylene glycol (PEG) is widely recognized as the gold standard for surface modification of nanomedicines, some shortcomings associated with this PEGylation, such as hindered cell endocytosis and accelerated blood clearance phenomenon, have been revealed in recent years. Notably, polysarcosine (PSar) as a highly biocompatible polymer can be finely synthesized by mild ring-opening polymerization (ROP) of sarcosine N-carboxyanhydrides (Sar-NCAs) and exhibit great potential as an alternative to PEG. In this article, PSar-b-polycamptothecin block copolymers are synthesized by sequential ROP of camptothecin-based NCAs (CPT-NCAs) and Sar-NCAs. Then, the detailed and systematic comparison between PEGylation and PSarylation against the 4T1 tumor model indicates that PSar decoration can facilitate the cell endocytosis, greatly enhancing the ICD effects and antitumor efficacy. Therefore, it is believed that this well-developed PSarylation technique will achieve effective and precise cancer treatment in the near future.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Flexible Electronics (Future Technologies) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211816, China.
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, China.
ORCID profiles: Xikuang Yao, Weina Zhang, Wenpei Fan, Fengwei Huo
Funding
- China Pharmaceutical University
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of the Jiangsu Higher Education Institutions
Cite
APA
Yao, X., Sun, C., Xiong, F., Zhang, W., Yao, W., Xu, Y., Fan, W., & Huo, F. (2024). Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c00166
Vancouver
Yao X, Sun C, Xiong F, Zhang W, Yao W, Xu Y, et al. Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c00166
BibTeX
@article{Yao2024,
author = {Yao, Xikuang and Sun, Changrui and Xiong, Fei and Zhang, Weina and Yao, Wenjing and Xu, Yinghui and Fan, Wenpei and Huo, Fengwei},
title = {Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c00166}
}
EUVIMED